+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Merck & Co., Inc. - logo

Merck & Co., Inc. is a global healthcare company with operations in more than 140 countries. It offers therapeutic and preventive agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus and other diseases. The company has collaboration agreements with Adaptimmune Therapeutics plc and Agenus; and a research agreement with Proteros Biostructures. Founded in 1891, it is headquartered in Kenilworth, New Jersey.

From
GLP-1 Analogues - Global Strategic Business Report - Product Thumbnail Image

GLP-1 Analogues - Global Strategic Business Report

  • Report
  • July 2025
  • 474 Pages
  • Global
From
Pancreatic Cancer Drugs - Global Strategic Business Report - Product Thumbnail Image

Pancreatic Cancer Drugs - Global Strategic Business Report

  • Report
  • July 2025
  • 151 Pages
  • Global
From
From
Nasopharyngeal Cancer Market Report and Forecast 2024-2032 - Product Thumbnail Image

Nasopharyngeal Cancer Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Synovial Sarcoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Synovial Sarcoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Neuroendocrine Carcinoma Market Report and Forecast 2024-2032 - Product Thumbnail Image

Neuroendocrine Carcinoma Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
From
From
From
Rabies Treatment Market 2020-2024 - Product Thumbnail Image

Rabies Treatment Market 2020-2024

  • Report
  • December 2020
  • 120 Pages
  • Global
From
Disease Analysis: HR+/HER2- Breast Cancer - Product Thumbnail Image

Disease Analysis: HR+/HER2- Breast Cancer

  • Report
  • May 2021
  • 97 Pages
  • Global
Loading Indicator